Drawing for BIOSYNTH

USPTO serial 87069542

BIOSYNTH

Reviewed by CopyMark Law Group

Reg. 5287408Status 702Renewal
Filing date
Status date
Registration date
Sep 12, 2017
Examiner
GEARHART, DAVID JAMES
Law office
TMO LAW OFFICE 112

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with BIOSYNTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tara Reedy Sliva

Tara Reedy Sliva DENTONS US LLPP.O. Box 1302CHICAGO, IL 60604United States

Goods and services

ClassDescriptionStatusFirst use
005Medicinal preparations for photosensitizing agents used as a dermatologic drug or prodrug for the treatment of skin cancer by phototherapy; Chemical reagents for medical and veterinarian use; Chemical reagents for cultures of microorganisms for medical use, namely, in culture media for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Chemical preparations for medical purposes, namely, for immunology research; Organic chemical preparations for medical purposes, namely, immunomodulatory compounds with anti-inflammatory properties; Organic chemical preparations for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, used as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); Medical enzymeACTIVESep 29, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 18, 2026E89RTEAS SECTION 8 & 9 RECEIVED—
Sep 12, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 12, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 12, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 12, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 14, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Sep 12, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 18, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 18, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 12, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 10, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 9, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 9, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 5, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 11, 2017IUAFUSE AMENDMENT FILED—
Jul 11, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 11, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 17, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 22, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 22, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 2, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 18, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 17, 2016ALIEASSIGNED TO LIE—
Sep 30, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 27, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Sep 27, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 27, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 27, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 22, 2016DOCKASSIGNED TO EXAMINER—
Jun 20, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 16, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance